Skip to main content
. Author manuscript; available in PMC: 2018 Mar 1.
Published in final edited form as: Clin Colorectal Cancer. 2016 Aug 9;16(1):23–30. doi: 10.1016/j.clcc.2016.07.016

Table 5.

Concordance of post-assay treatment recommendations and decisions between physicians and patients.

Post-assay Physician Recommendations Post-assay Patient Decisions
Observation 5FU-based monotherapy 5FU + Oxaliplatin Other Total
Observation 98
70.5%
0 0 0 98
70.5%
5FU-based monotherapy 0 16
11.5%
0 1
0.7%
17
12.2%
5FU +Oxaliplatin 5
3.6%
1
0.7%
15
10.8%
1
0.72
22
15.8%
Other 1
0.7%
0 0 1
0.72
2
1.4%
Total 104
74.8%
17
12.2%
15
10.8%
3
2.2%
139
100.0%